-
公开(公告)号:US20210171545A1
公开(公告)日:2021-06-10
申请号:US16944581
申请日:2020-07-31
Applicant: Integral Early Discovery, Inc. , Genentech, Inc.
Inventor: Kenneth W. Bair , Timm R. Baumeister , Peter Dragovich , Xiongcai Liu , Snahel Patel , Po-Wai Yuen , Mark Zak , Guiling Zhao , Yamin Zhang , Xiaozhang Zheng
IPC: C07D519/00 , C07D495/04 , C07D471/04 , C07D487/04 , C07D491/048 , A61K31/438 , A61K31/496 , A61K31/497 , A61K31/501 , A61K31/519 , A61K31/5377 , A61K31/541 , A61K45/06 , A61K31/444 , A61K31/4545 , A61K31/506 , A61K31/513
Abstract: Provided are amido spirocyclic amide and sulfonamide compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.
-
公开(公告)号:US10696692B2
公开(公告)日:2020-06-30
申请号:US14382141
申请日:2013-03-01
Applicant: Forma TM, LLC , Genentech, Inc.
Inventor: Kenneth W Bair , Timm R Baumeister , Alexandre J Buckmelter , Karl H Clodfelter , Peter Dragovich , Francis Gosselin , Janet Gunzner-Toste , Bingsong Han , Jian Lin , Xiongcai Liu , Dominic J Reynolds , Chase C Smith , Zhongguo Wang , Mark Zak , Yamin Zhang , Guiling Zhao , Xiaozhang Zheng , Po-Wai Yuen
IPC: A61K51/00 , A61M36/14 , C07D519/00 , C07D471/04 , C07D495/04 , C07D487/04 , C07D491/048 , A61K31/454 , A61K31/4545 , A61K31/46 , A61K31/496 , A61K31/5025 , A61K31/5377 , A61K31/5386 , A61K31/551 , A61K45/06
Abstract: The present invention relates to certain amido-benzyl sulfoxide and sulfone compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.
-
公开(公告)号:US10307426B2
公开(公告)日:2019-06-04
申请号:US15984747
申请日:2018-05-21
Applicant: Genentech, Inc.
Inventor: Mark Zak , F. Anthony Romero , Yun-Xing Cheng
IPC: C07D487/04 , A61K31/519 , A61P11/06 , A61P29/00
Abstract: Compounds and salts thereof that are useful as JAK kinse inhibitors are described herein. Also provided are pharmaceutical compositions that include such a JAK inhibitor and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.
-
公开(公告)号:US20190071404A1
公开(公告)日:2019-03-07
申请号:US16181228
申请日:2018-11-05
Applicant: Genentech, Inc.
Inventor: James John Crawford , Mark Zak , Terry Kellar , Yun-Xing Cheng , Wei Li , F. Anthony Romero , Paul Gibbons , Guiling Zhao , Gregory Hamilton , Simon Charles Goodacre
IPC: C07D231/40 , C07D401/04 , C07D405/04 , C07D403/08 , C07D409/14 , C07D401/14 , C07D405/12
Abstract: Compounds of Formula (I): and salts thereof, and methods of use as Janus kinase inhibitors are described herein.
-
公开(公告)号:US20180354959A1
公开(公告)日:2018-12-13
申请号:US16104347
申请日:2018-08-17
Applicant: Genentech, Inc.
Inventor: Mark Zak , Terry Kellar , Paul Gibbons
IPC: C07D487/04
CPC classification number: C07D487/04
Abstract: Compounds of Formula (I): salts thereof and methods of use as Janus kinase inhibitors are described herein.
-
公开(公告)号:US20180339998A1
公开(公告)日:2018-11-29
申请号:US15936086
申请日:2018-03-26
Applicant: Forma TM, LLC , Genentech, Inc.
Inventor: Kenneth W. Bair , Timm R. Baumeister , Peter Dragovich , Xiongcai Liu , Snahel Patel , Po-Wai Yuen , Mark Zak , Guiling Zhao , Yamin Zhang , Xiaozhang Zheng
IPC: C07D519/00 , A61K45/06 , C07D471/04 , A61K31/519 , A61K31/5377 , A61K31/541 , A61K31/496 , A61K31/497 , A61K31/513 , A61K31/444 , A61K31/4545 , A61K31/506 , A61K31/438 , C07D495/04 , C07D491/048 , C07D487/04 , A61K31/501
Abstract: Provided are amido spirocyclic amide and sulfonamide compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.
-
17.Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyrase 失效
Title translation: 吡咯并嘧啶酮和吡咯并吡啶酮抑制剂公开(公告)号:US08722661B2
公开(公告)日:2014-05-13
申请号:US13911601
申请日:2013-06-06
Applicant: Genentech, Inc.
Inventor: Nancy-Ellen Haynes , Johannes Hermann , Kyungjin Kim , Nathan Robert Scott , Lin Yi , Mark Zak
IPC: A61K31/00 , C07D401/00 , C07D487/00 , C07D471/02
CPC classification number: C07D487/04 , C07D471/04
Abstract: There are provided compounds of the formula (I) wherein Q, R1 and R2 are defined herein. The compounds have activity as anticancer agents.
Abstract translation: 提供式(I)化合物,其中Q,R 1和R 2在本文中定义。 该化合物具有作为抗癌剂的活性。
-
-
-
-
-
-